• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过热位移分析寻找蛋白质稳定药物。

Looking for protein stabilizing drugs with thermal shift assay.

作者信息

Andreotti Giuseppina, Monticelli Maria, Cubellis Maria Vittoria

机构信息

Istituto di Chimica Biomolecolare -CNR, Pozzuoli, Italy.

Dipartimento di Biologia, Università Federico II, Napoli, Italy.

出版信息

Drug Test Anal. 2015 Sep;7(9):831-4. doi: 10.1002/dta.1798. Epub 2015 Apr 5.

DOI:10.1002/dta.1798
PMID:25845367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6681132/
Abstract

Thermal shift assay can be used for the high-throughput screening of pharmacological chaperones. These drugs are small molecules that bind a mutant protein and stabilize it. We demonstrated the robustness, reproducibility and versatility of the method using two molecules that are in clinical trial for Fabry or Pompe disease, Deoxygalactonojirimycin and N-Butyldeoxynojirimycin, and their target enzymes, lysosomal alpha-galactosidaseA and alpha-glucosidase, as test cases. We assessed the influence of solvents and of scanning rate on the measures. We showed that a value that is equivalent to the melting temperature can be obtained by the first derivatives of raw data. We discuss the advantages of the method and the precaution to be taken in running the experiments.

摘要

热位移分析可用于药物伴侣分子的高通量筛选。这些药物是与突变蛋白结合并使其稳定的小分子。我们以两种正在进行法布里病或庞贝病临床试验的分子——脱氧半乳糖野尻霉素和N - 丁基脱氧野尻霉素,以及它们的靶酶溶酶体α - 半乳糖苷酶A和α - 葡萄糖苷酶作为测试案例,证明了该方法的稳健性、可重复性和通用性。我们评估了溶剂和扫描速率对测量结果的影响。我们表明,通过原始数据的一阶导数可以获得与熔解温度等效的值。我们讨论了该方法的优点以及进行实验时应采取的预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ac/6681132/4da3636291bc/DTA-7-831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ac/6681132/9f10505e4aea/DTA-7-831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ac/6681132/4da3636291bc/DTA-7-831-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ac/6681132/9f10505e4aea/DTA-7-831-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ac/6681132/4da3636291bc/DTA-7-831-g002.jpg

相似文献

1
Looking for protein stabilizing drugs with thermal shift assay.通过热位移分析寻找蛋白质稳定药物。
Drug Test Anal. 2015 Sep;7(9):831-4. doi: 10.1002/dta.1798. Epub 2015 Apr 5.
2
Enzyme enhancers for the treatment of Fabry and Pompe disease.用于治疗法布里病和庞贝病的酶增强剂。
Mol Ther. 2015 Mar;23(3):456-64. doi: 10.1038/mt.2014.224. Epub 2014 Nov 20.
3
Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human α-galactosidase a: pharmacological chaperoning efficacy on Fabry disease mutants.1-脱氧半乳糖基氮杂环庚烷硫脲与人α-半乳糖苷酶 A 结合的分子基础:法布里病突变体的药理学伴侣效应。
ACS Chem Biol. 2014 Jul 18;9(7):1460-9. doi: 10.1021/cb500143h. Epub 2014 May 12.
4
In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives.1-脱氧半乳糖野尻霉素及其衍生物对法布里病淋巴母细胞中溶酶体α-半乳糖苷酶A活性的体外抑制和细胞内增强作用
Eur J Biochem. 2000 Jul;267(13):4179-86. doi: 10.1046/j.1432-1327.2000.01457.x.
5
The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts.药理学伴侣N-丁基脱氧野尻霉素增强了庞贝病成纤维细胞中的酶替代疗法。
Mol Ther. 2009 Jun;17(6):964-71. doi: 10.1038/mt.2009.53. Epub 2009 Mar 17.
6
The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines.药理学伴侣1-脱氧半乳糖野尻霉素可提高法布里病患者细胞系中α-半乳糖苷酶A的水平。
J Inherit Metab Dis. 2009 Jun;32(3):424-40. doi: 10.1007/s10545-009-1077-0. Epub 2009 Apr 18.
7
Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants.药理学伴侣可纠正由转运功能缺陷变体引起的法布里病中的溶酶体贮积。
Am J Physiol Cell Physiol. 2006 Apr;290(4):C1076-82. doi: 10.1152/ajpcell.00426.2005.
8
Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.在具有残余酶活性的法布里病患者中鉴定出的突变α-半乳糖苷酶A酶:生化特性及1-脱氧半乳糖野尻霉素对正常细胞内加工的恢复作用
Biochem J. 2007 Sep 1;406(2):285-95. doi: 10.1042/BJ20070479.
9
Pharmacological chaperone therapy for Fabry disease.法布雷病的药物伴侣治疗。
Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(1):18-30. doi: 10.2183/pjab.88.18.
10
The molecular basis of pharmacological chaperoning in human α-galactosidase.人类α-半乳糖苷酶药理伴侣作用的分子基础。
Chem Biol. 2011 Dec 23;18(12):1521-6. doi: 10.1016/j.chembiol.2011.10.012.

引用本文的文献

1
Targeting protein disorder: the next hurdle in drug discovery.靶向蛋白质无序状态:药物研发的下一个障碍。
Nat Rev Drug Discov. 2025 Jun 9. doi: 10.1038/s41573-025-01220-6.
2
Boosting Fructosyl Transferase's Thermostability and Catalytic Performance for Highly Efficient Fructooligosaccharides (FOS) Production.提高果糖基转移酶的热稳定性和催化性能以高效生产低聚果糖
Foods. 2024 Sep 21;13(18):2997. doi: 10.3390/foods13182997.
3
Structural insights into binding of polyglutamylated tetrahydrofolate by serine hydroxymethyltransferase 8 from soybean.

本文引用的文献

1
Analysis of protein stability and ligand interactions by thermal shift assay.通过热迁移分析进行蛋白质稳定性和配体相互作用的分析。
Curr Protoc Protein Sci. 2015 Feb 2;79:28.9.1-28.9.14. doi: 10.1002/0471140864.ps2809s79.
2
Conformational response to ligand binding in phosphomannomutase2: insights into inborn glycosylation disorder.磷酸甘露糖变位酶2中配体结合的构象反应:对先天性糖基化障碍的见解
J Biol Chem. 2014 Dec 12;289(50):34900-10. doi: 10.1074/jbc.M114.586362. Epub 2014 Oct 16.
3
A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy.
大豆丝氨酸羟甲基转移酶8对聚谷氨酸化四氢叶酸结合的结构见解。
Front Plant Sci. 2024 Aug 19;15:1451839. doi: 10.3389/fpls.2024.1451839. eCollection 2024.
4
Use of TSAR, Thermal Shift Analysis in R, to identify Folic Acid as a Molecule that Interacts with HIV-1 Capsid.使用TSAR(R语言中的热位移分析)来鉴定叶酸作为一种与HIV-1衣壳相互作用的分子。
bioRxiv. 2023 Nov 29:2023.11.29.569293. doi: 10.1101/2023.11.29.569293.
5
Nanomolar Protein Thermal Profiling with Modified Cyanine Dyes.利用改良型菁染料进行纳摩尔级别的蛋白质热分析。
Anal Chem. 2023 Dec 19;95(50):18344-18351. doi: 10.1021/acs.analchem.3c02844. Epub 2023 Dec 7.
6
Combining multi-omics analysis to identify host-targeted targets for the control of Brucella infection.结合多组学分析鉴定控制布鲁氏菌感染的宿主靶向靶标。
Microb Biotechnol. 2023 Dec;16(12):2345-2366. doi: 10.1111/1751-7915.14307. Epub 2023 Oct 26.
7
Screening of Buffers and Additives for Protein Stabilization by Thermal Shift Assay: A Practical Approach.热位移分析筛选蛋白质稳定剂的缓冲液和添加剂:实用方法。
Methods Mol Biol. 2023;2652:199-213. doi: 10.1007/978-1-0716-3147-8_11.
8
Enzyme Replacement Therapy for FABRY Disease: Possible Strategies to Improve Its Efficacy.法布里病的酶替代疗法:提高疗效的可能策略。
Int J Mol Sci. 2023 Feb 25;24(5):4548. doi: 10.3390/ijms24054548.
9
Cryo-EM structure of adeno-associated virus 4 at 2.2 Å resolution.腺相关病毒 4 的 2.2 Å 分辨率冷冻电镜结构。
Acta Crystallogr D Struct Biol. 2023 Feb 1;79(Pt 2):140-153. doi: 10.1107/S2059798322012190. Epub 2023 Jan 20.
10
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease.姜黄素对溶酶体α-半乳糖苷酶具有有益作用:对法布里病治疗的潜在意义。
Int J Mol Sci. 2023 Jan 6;24(2):1095. doi: 10.3390/ijms24021095.
伴侣蛋白可增强接受酶替代疗法治疗的庞贝病患者的血液α-葡萄糖苷酶活性。
Mol Ther. 2014 Nov;22(11):2004-12. doi: 10.1038/mt.2014.138. Epub 2014 Jul 23.
4
Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation.磷酸甘露糖变位酶 2 相关糖基化障碍的常见致病突变的生化表型和可能的治疗方法。
Mol Genet Genomic Med. 2013 May;1(1):32-44. doi: 10.1002/mgg3.3. Epub 2013 Mar 27.
5
A thermodynamic assay to test pharmacological chaperones for Fabry disease.一种用于检测法布里病药理伴侣分子的热力学分析方法。
Biochim Biophys Acta. 2014 Mar;1840(3):1214-24. doi: 10.1016/j.bbagen.2013.12.018. Epub 2013 Dec 21.
6
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones.FabryCEP:一种识别对药物伴侣有反应的 Fabry 突变的工具。
Orphanet J Rare Dis. 2013 Jul 24;8:111. doi: 10.1186/1750-1172-8-111.
7
2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept.2-(3-氧代-1,3-二苯基丙基)丙二酸作为磷酸肌醇依赖性激酶-1 的 PIF 口袋的有效变构配体:开发和前药概念。
J Med Chem. 2012 Nov 26;55(22):9817-30. doi: 10.1021/jm3010477. Epub 2012 Nov 12.
8
Co-administration with the pharmacological chaperone AT1001 increases recombinant human α-galactosidase A tissue uptake and improves substrate reduction in Fabry mice.与药理学伴侣 AT1001 联合给药可增加重组人α-半乳糖苷酶 A 的组织摄取,并改善法布里小鼠的底物减少。
Mol Ther. 2012 Apr;20(4):717-26. doi: 10.1038/mt.2011.271. Epub 2012 Jan 3.
9
The molecular basis of pharmacological chaperoning in human α-galactosidase.人类α-半乳糖苷酶药理伴侣作用的分子基础。
Chem Biol. 2011 Dec 23;18(12):1521-6. doi: 10.1016/j.chembiol.2011.10.012.
10
Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics.用药理学伴侣分子治疗溶酶体贮积症:从概念到临床。
EMBO Mol Med. 2009 Aug;1(5):268-79. doi: 10.1002/emmm.200900036.